Sesame Summit 2026 – application open

Lifebloom raises €8 million to deploy robotic exoskeleton walking therapy across France

Growing investment in rehabilitation robotics

The funding, which closed in late March 2026, comprises €6 million in equity from a consortium of family offices, entrepreneurs, and private investors, supplemented by €2 million in non-dilutive financing awarded through the France 2030 national investment programme. The blended structure reflects a pattern increasingly common among European medtech startups, where government innovation grants complement private capital to derisk the commercialisation of novel therapeutic devices.

Lifebloom’s core product, the Lifebloom One, is a robotic exoskeleton system designed to restore autonomous walking in patients with reduced mobility — conditions stemming from neurological injuries, strokes, spinal cord damage, and age-related mobility decline. Unlike fitness-oriented wearable robotics, the Lifebloom One is a clinical rehabilitation tool, deployed within healthcare facilities under medical supervision as part of structured therapy programmes.

Scaling deployment across French healthcare facilities

The primary use of funds is the rapid deployment of Lifebloom’s Walking Units, with the company targeting 30 healthcare facilities across France within the coming year. This rollout strategy is critical: exoskeleton rehabilitation technology has shown clinical promise for over a decade, but adoption has been constrained by high unit costs, limited insurance reimbursement pathways, and the need for specialised clinical training. Lifebloom’s approach — providing integrated walking units rather than standalone exoskeletons — is designed to lower the operational barrier for rehabilitation centres, packaging the hardware, software, and clinical support into a deployable system.

The company’s longer-term target is ambitious: enabling 1,000 patients to regain autonomous walking by 2028. While the number may appear modest in absolute terms, it represents a significant milestone in a field where each successful rehabilitation outcome requires dozens of supervised therapy sessions and careful patient selection.

European medtech finds its stride in rehabilitation robotics

Lifebloom’s funding arrives during a period of growing investor interest in rehabilitation and assistive robotics across Europe. The global rehabilitation robotics market, valued at approximately $1.2 billion in 2025, is projected to grow at a compound annual rate exceeding 20 per cent through the end of the decade, driven by ageing populations, rising stroke incidence, and mounting pressure on healthcare systems to deliver cost-effective long-term care.

In France specifically, the government’s France 2030 programme has emerged as a significant catalyst for medtech innovation, providing non-dilutive capital to companies developing breakthrough health technologies. The programme’s backing of Lifebloom signals institutional confidence in exoskeleton therapy as a viable component of France’s future rehabilitation infrastructure — a vote of confidence that may help accelerate regulatory and reimbursement pathways for the category.

Founded in 2019 and headquartered in Lille, Lifebloom has spent the intervening years refining its technology and building clinical evidence. The transition from development to deployment — marked by this funding round — represents the classic inflection point for European medtech companies: the moment when a promising laboratory technology must prove it can scale within the practical constraints of real-world healthcare delivery.

For the consortium of family offices and private investors backing the round, the thesis rests on a straightforward demographic reality: Europe’s population is ageing, its healthcare workforce is shrinking, and technologies that can multiply the effectiveness of rehabilitation professionals will command growing value. Lifebloom’s challenge now is execution — placing its Walking Units in clinics, training therapists, and generating the patient outcome data that will underpin broader adoption.


Summary

  • Company: Lifebloom
  • HQ: Lille, France
  • Founded: 2019
  • Round: Seed (equity + France 2030 grant)
  • Amount: €8 million (€6M equity + €2M non-dilutive)
  • Investors: Consortium of family offices, entrepreneurs, and private investors; France 2030 programme
  • Use of funds: Deployment of Walking Units across 30 French healthcare facilities; target of 1,000 patients walking autonomously by 2028

you might also like

Fundraising 3 hours ago

London-based AI laboratory Ineffable Intelligence has emerged from stealth with a $1.1 billion seed round at a $5.1 billion post-money valuation, the company confirmed on 27 April 2026. The financing is the largest seed round ever raised by a European company and one of the largest first-money-in rounds in the global history of artificial intelligence. The round was co-led by Sequoia Capital and Lightspeed Venture Partners. Participating investors included Nvidia, DST Global, Index Ventures, Google, and the UK Sovereign AI Fund, the British government’s recently established vehicle for backing strategic AI capacity on home soil. A bet on a different path to general intelligence Ineffable Intelligence was founded in 2025 by David Silver, the former Vice President of Reinforcement Learning at Google DeepMind and the principal architect of AlphaGo, AlphaZero and AlphaStar. He is joined by three further DeepMind alumni: Wojciech Czarnecki, Lasse Espeholt and Junhyuk Oh. All four have spent the past decade at the frontier of reinforcement learning research, the discipline behind some of the most consequential demonstrations of machine learning over the past ten years. The company describes its objective as building a “superlearner” — an AI system capable of acquiring knowledge directly from its own experience rather than from human-generated text or imagery. “Our mission is to make first contact with superintelligence,” Silver said in a statement accompanying the launch. “We are creating a superlearner that discovers all knowledge from its own experience, from elementary motor skills through to profound intellectual breakthroughs.” The framing is a deliberate departure from the dominant industry trajectory. Most leading AI laboratories, including OpenAI, Anthropic and Google DeepMind itself, have built large language models trained primarily on the corpus of the internet, then refined that training with human feedback. Ineffable’s wager is that the marginal returns on scaling text-based pretraining are diminishing and that the next leap in capability will come from agents that learn endlessly from the consequences of their own actions, in much the same way AlphaZero learnt the game of Go without studying any human matches. Why $1.1 billion at seed The size of the round is unusual even by the inflated standards of the 2026 AI capital cycle. Two factors appear to explain it. First, frontier reinforcement learning at the scale Ineffable describes is computationally extraordinarily expensive: the company will need to operate vast simulation environments and train very large models against them, an undertaking that consumes capital at a rate closer to physical R&D than to traditional software. Second, the round signals a strategic move by Europe’s investor and policy ecosystems to retain the most ambitious AI researchers on the continent. The presence of the UK Sovereign AI Fund alongside Sequoia, Lightspeed and Nvidia is the clearest expression of that intent. The British government has publicly framed the investment as a bet on breakthrough AI that “can discover new knowledge”, positioning the country as a willing co-investor in domestic frontier laboratories. For Ineffable, the implication is access not only to capital but to compute, regulatory engagement and the still-resilient academic talent base around UCL, Oxford, Cambridge and Imperial. Founder pledge of historic scale Alongside the funding announcement, Silver disclosed that he is committing 100 per cent of any personal proceeds from his Ineffable equity to charity via the Founders Pledge network — described by the organisation as the largest pledge in its history. At the round’s $5.1 billion valuation, that commitment could ultimately exceed several billion dollars if the company succeeds. It is a meaningful gesture in a sector where the reputational stakes around concentrated AI wealth are escalating, and one likely to be referenced in subsequent founder-led commitments. Implications for the European AI landscape Ineffable’s emergence reshapes the European AI map in three concrete ways. It establishes London as the home of the continent’s largest-ever seed-stage company, complicating Paris’s recent narrative of frontier-AI primacy after Mistral’s earlier rounds. It validates a thesis — that reinforcement learning, not transformer scaling, is the next frontier — that has lately been losing capital share to language-model incumbents. And it confirms that the UK government is now willing to act as a balance-sheet co-investor in domestic AI laboratories, a posture much closer to the French model than to the predominantly grant-based regimes elsewhere in Europe. The execution risk is non-trivial. Reinforcement learning at frontier scale has historically required years of careful environment design before producing competitive systems, and Ineffable’s “first contact” framing sets a high bar against which it will be judged. But for now, with a billion dollars on the balance sheet, four of the discipline’s most accomplished researchers in the founding team and a sovereign co-investor at its back, Ineffable Intelligence is the most heavily resourced new entrant in the European AI cycle. Sesamers covers European fundraising rounds across deeptech, fintech and AI. Source: tech.eu.

Fundraising 5 days ago

Belfast's Cloudsmith has raised $72M Series C led by TCV, with Insight Partners participating, to expand its artifact management platform and secure the AI-era software supply chain.

Fundraising 5 days ago

Berlin’s VREY has raised €3.3M seed led by Rubio Impact Ventures to roll out rooftop solar software for Germany’s multi-family buildings.

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.